Nagashima Y - Search Results

1

Reduced excision repair cross-complementing 1 expression associates with enhanced papilloma formation and fibroblast transformation after genetic disruption of secreted protein acidic and rich in cysteine.

Kato Y, Tsukuda M, Nagashima Y, Koshika S, Sakai N, Yao M, Kubota Y, Aoki I, Colledge WH, Foidart JM, Hata R, Thompson EW. Kato Y, et al. Among authors: nagashima y. Int J Oncol. 2005 Sep;27(3):759-68. Int J Oncol. 2005. PMID: 16077926

2

High production of SPARC/osteonectin/BM-40 in mouse metastatic B16 melanoma cell lines.

Kato Y, Frankenne F, Noël A, Sakai N, Nagashima Y, Koshika S, Miyazaki K, Foidart JM. Kato Y, et al. Among authors: nagashima y. Pathol Oncol Res. 2000;6(1):24-6. doi: 10.1007/BF03032654. Pathol Oncol Res. 2000. PMID: 10749584 Free article.

3

Expression of SPARC in tongue carcinoma of stage II is associated with poor prognosis: an immunohistochemical study of 86 cases.

Kato Y, Nagashima Y, Baba Y, Kawano T, Furukawa M, Kubota A, Yanoma S, Imagawa-Ishiguro Y, Satake K, Taguchi T, Hata R, Mochimatsu I, Aoki I, Kameda Y, Inayama Y, Tsukuda M. Kato Y, et al. Among authors: nagashima y. Int J Mol Med. 2005 Aug;16(2):263-8. Int J Mol Med. 2005. PMID: 16012759

4

Stimulation of motility of human renal cell carcinoma by SPARC/Osteonectin/BM-40 associated with type IV collagen.

Kato Y, Sakai N, Baba M, Kaneko S, Kondo K, Kubota Y, Yao M, Shuin T, Saito S, Koshika S, Kawase T, Miyagi Y, Aoki I, Nagashima Y. Kato Y, et al. Among authors: nagashima y. Invasion Metastasis. 1998-1999;18(2):105-14. doi: 10.1159/000024503. Invasion Metastasis. 1998. PMID: 10364690

5

Induction of SPARC by VEGF in human vascular endothelial cells.

Kato Y, Lewalle JM, Baba Y, Tsukuda M, Sakai N, Baba M, Kobayashi K, Koshika S, Nagashima Y, Frankenne F, Noël A, Foidart JM, Hata RI. Kato Y, et al. Among authors: nagashima y. Biochem Biophys Res Commun. 2001 Sep 21;287(2):422-6. doi: 10.1006/bbrc.2001.5622. Biochem Biophys Res Commun. 2001. PMID: 11554745 Free article.

6

Pathological and molecular biological aspects of the renal epithelial neoplasms, up-to-date.

Nagashima Y, Inayama Y, Kato Y, Sakai N, Kanno H, Aoki I, Yao M. Nagashima Y, et al. Pathol Int. 2004 Jun;54(6):377-86. doi: 10.1111/j.1440-1827.2004.01648.x. Pathol Int. 2004. PMID: 15144395 Review.

7

Transition of organizational category on renal cancer.

Nagashima Y, Kuroda N, Yao M. Nagashima Y, et al. Jpn J Clin Oncol. 2013 Mar;43(3):233-42. doi: 10.1093/jjco/hyt006. Epub 2013 Feb 6. Jpn J Clin Oncol. 2013. PMID: 23390307 Review.

8

A three-gene expression signature model to predict clinical outcome of clear cell renal carcinoma.

Yao M, Huang Y, Shioi K, Hattori K, Murakami T, Sano F, Baba M, Kondo K, Nakaigawa N, Kishida T, Nagashima Y, Yamada-Okabe H, Kubota Y. Yao M, et al. Among authors: nagashima y. Int J Cancer. 2008 Sep 1;123(5):1126-32. doi: 10.1002/ijc.23641. Int J Cancer. 2008. PMID: 18546273

9

Expression of aquaporin 1 in primary renal tumors: a prognostic indicator for clear-cell renal cell carcinoma.

Huang Y, Murakami T, Sano F, Kondo K, Nakaigawa N, Kishida T, Kubota Y, Nagashima Y, Yao M. Huang Y, et al. Among authors: nagashima y. Eur Urol. 2009 Oct;56(4):690-8. doi: 10.1016/j.eururo.2008.10.014. Epub 2008 Oct 14. Eur Urol. 2009. PMID: 18930582

10

Identification of miR-30d as a novel prognostic maker of prostate cancer.

Kobayashi N, Uemura H, Nagahama K, Okudela K, Furuya M, Ino Y, Ito Y, Hirano H, Inayama Y, Aoki I, Nagashima Y, Kubota Y, Ishiguro H. Kobayashi N, et al. Among authors: nagashima y. Oncotarget. 2012 Nov;3(11):1455-71. doi: 10.18632/oncotarget.696. Oncotarget. 2012. PMID: 23231923 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,121 results

Search Page

Filters